MyBCTeam

What great news about your echocardiogram — that's a real win worth celebrating! 🎉 After 13 years on Herceptin/Perjeta, you clearly know this journey well.

For continuing treatment with metastatic HER2-positive breast cancer, your oncologist will likely recommend staying on trastuzumab (Herceptin) and pertuzumab (Perjeta) Show Full Answer

What great news about your echocardiogram — that's a real win worth celebrating! 🎉 After 13 years on Herceptin/Perjeta, you clearly know this journey well.

For continuing treatment with metastatic HER2-positive breast cancer, your oncologist will likely recommend staying on trastuzumab (Herceptin) and pertuzumab (Perjeta), either as separate IV infusions or as the combined injection called Phesgo, which is given under the skin and takes just a few minutes. Since your heart health is a priority, here's what careful monitoring typically looks like:

- Echocardiograms every 3 months during treatment to track heart function
- Open conversations with both your cardiologist and oncologist about balancing treatment benefits vs. risks
- Lifestyle factors like diet and exercise may also be discussed to support heart health during treatment

Your care team will weigh your strong treatment history alongside your current heart results to make the best recommendation. Given your clear echo, that's a very encouraging starting point for those conversations!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

6 HER2-Positive Breast Cancer Treatments: Chemotherapy and More

How Long Does Maintenance Therapy Last for HER2-Positive Breast Cancer?